FutureFuel Corporation: A Forgotten Small Cap with Two Engines

A Boring Chemical Stock That Could Explode Once the Rules Change

The Business

FutureFuel Corporation (NYSE: FF) operates two complementary businesses: biofuels and specialty chemicals. From its fully integrated plant in Batesville, Arkansas, the company manufactures biodiesel from vegetable oils, animal fats, and used cooking oils and produces customized chemicals for industrial clients across coatings, polymers, and detergents.

In mid-2025, FutureFuel temporarily idled its biodiesel production due to uncertainty surrounding the implementation of the new IRA 45Z Clean Fuel Producer Tax Credit, which replaces the expired Blenders’ Tax Credit. With unclear guidance from U.S. regulators, management chose to pause output and focus resources on the higher-margin specialty chemicals segment, where demand remains steadier.

In Q3 2024, revenue fell 56 % year-on-year to $51 million, and the company posted a net loss of $1.2 million (–$0.03 per share). Adjusted EBITDA came in at roughly –$1 million. The decline came mainly from weaker biodiesel sales and lower agricultural input prices.

Despite that, FutureFuel maintained a solid balance sheet with limited debt and cash reserves allowing operational flexibility.

The Big Strength I Identified

FutureFuel’s core advantage is adaptability. Its Batesville facility can shift capacity between fuel and chemical production based on market conditions and policy signals. Most small-cap biofuel players lack that flexibility and remain tied to volatile refining margins; FutureFuel can step back, regroup, and redeploy.

The specialty chemicals division provides a more predictable foundation. FutureFuel has decades of know-how in complex organic chemistry: chlorination, esterification, polymer modification and long-standing relationships with major industrial customers.

That part of the business generates stable, recurring cash flow and protects the downside when the fuel cycle turns.

If and when federal tax credit clarity returns, the company could restart biodiesel output quickly with low incremental capex, capturing upside from improving spreads. The optionality between chemicals and fuels is the essence of the model: flexibility creates embedded leverage.

What’s Ahead

2025 will be a transitional year. The focus is on stabilizing specialty chemicals, optimizing working capital, and waiting for Washington’s final 45Z guidance before reactivating biodiesel operations. The potential catalyst is clear: regulatory clarity plus cost discipline.

FutureFuel is also developing new products within its chemical portfolio, such as polymer additives and specialty solvents, to reduce dependency on legacy contracts. That R&D effort aims to reposition the company from a cyclical biofuel name toward a chemistry-first, clean-energy-option hybrid.

If chemical growth resumes and the policy backdrop improves, earnings power could normalize faster than the market expects.

The Management

Since late 2024, CEO Roeland Polet has led the company through this realignment. His background combines chemical engineering and global manufacturing management, a pragmatic fit for FutureFuel’s dual nature.

Under his watch, the company is prioritizing profitability and capital discipline rather than chasing production volume.

The message is clear: build stability first, keep the biofuel lever optional.

The Numbers of a Bagger

FutureFuel’s equity value hovers around $190 million, well below its historic mid-cycle EBITDA potential. The path to re-rating depends on:

• Returning the chemicals business to sustained growth and double-digit margins.

• Maintaining a conservative balance sheet with minimal leverage.

• Restarting biodiesel only when spreads justify it, turning sunk costs into incremental profit.

• Keeping SG&A lean and reinvesting selectively in high-margin chemical niches.

If normalized EBITDA eventually returns near historical levels around $40–60 million, the implied valuation multiple leaves room for a 2× to 4× upside over a few years, provided execution and policy align.

The Risks

The biggest risk is regulatory. If the IRA 45Z credit is delayed or proves less generous than expected, biodiesel could remain offline for longer. Feedstock volatility (soybean oil, tallow, used cooking oil) can erode margins fast.

The specialty chemical segment must also deliver consistent growth to offset lost fuel volume.

And as a small-cap stock, liquidity is thin, amplifying swings in both directions.

The Conclusion

FutureFuel stands in an awkward but interesting spot: too chemical for energy investors, too energy-linked for chemical investors. The market sees a stranded biodiesel producer; in reality, it’s a cash-conservative manufacturer with embedded optionality on the clean-fuel rebound.

If management keeps execution tight and the policy environment normalizes, this could quietly double or triple from current levels. Not in one quarter, but over a cycle.

I’m watching closely and may start a small pilot position.

Until next time,

Joshua.

Disclaimer: This analysis is provided for informational and educational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Investing in equities involves risk, including the potential loss of capital. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.